Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
6.79
+0.05 (0.74%)
Aug 11, 2026, 9:32 AM EDT - Market open

Clinuvel Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
32.5436.1735.6430.620.8824.73
Depreciation & Amortization
1.041.151.090.740.720.82
Loss (Gain) From Sale of Assets
----0.030.09
Stock-Based Compensation
226.118.996.122.6
Other Operating Activities
2.69-0.420.67-0.210.171.56
Change in Accounts Receivable
-1.22-1.22-4.02-6.01-0.11-9.48
Change in Inventory
1.811.81-1.11-7.691.35-1.9
Change in Accounts Payable
2.842.84-0.654.51-1.56-
Change in Income Taxes
-1.3-1.3-0.248.817.180.1
Change in Other Net Operating Assets
-0.87-0.870.07-1.41-0.97-0.14
Operating Cash Flow
40.4741.137.0536.9139.8719.26
Operating Cash Flow Growth
-1.53%10.91%0.38%-7.42%107.00%35.76%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-0.39-0.3-5.58-1.03-0.43-0.85
Investment in Securities
-18.25-47.42-23.46-30.82--
Investing Cash Flow
-18.64-47.72-29.03-31.85-0.43-0.85

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Long-Term Debt Repaid
--0.18-0.35-0.26-0.27-0.2
Net Debt Issued (Repaid)
-0.2-0.18-0.35-0.26-0.27-0.2
Issuance of Common Stock
0.190.194.16---
Repurchase of Common Stock
-0.19-0.44-4.91---
Common Dividends Paid
-2.51-2.5-2.47-1.98-1.24-1.24
Other Financing Activities
------0.04
Financing Cash Flow
-2.71-2.94-3.57-2.24-1.5-1.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
0.22.38-1.141.660.88-0.98
Miscellaneous Cash Flow Adjustments
00----
Net Cash Flow
19.32-7.183.314.4838.8215.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
40.0840.831.4835.8839.4418.41
Free Cash Flow Growth
-1.76%29.61%-12.28%-9.01%114.25%38.41%
Free Cash Flow Margin
41.62%42.94%35.70%45.82%60.01%38.10%
Free Cash Flow Per Share
0.790.810.620.690.760.36
Levered Free Cash Flow
32.229.9323.4532.3333.258.06
Unlevered Free Cash Flow
35.3532.7226.2334.3334.679.07

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
-----0.04
Cash Income Tax Paid
15.415.7315.657.74--
Change in Working Capital
2.22.2-6.44-3.2211.96-10.54
SEC Filings: 10-K · 10-Q